FFCP PHASE2:Hg19::chr17:56084961..56085010,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p3@SRSF1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_3_at_SRSF1_5end |
Coexpression cluster: | NA |
Association with transcript: | -254bp_to_ENST00000258962, NM_001078166, NM_006924, NR_034041, uc002ivi.2, uc002ivj.2_5end |
EntrezGene: | SRSF1 |
HGNC: | 10780 |
UniProt: | Q07955Q59FA2 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p3@SRSF1 |
---|
0.0
2.5
5.0
7.5
10.0
12.5
15.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 2.37e-40 | 235 |
disease of cellular proliferation | 1.16e-39 | 239 |
cell type cancer | 4.59e-22 | 143 |
carcinoma | 3.17e-19 | 106 |
organ system cancer | 1.20e-18 | 137 |
hematologic cancer | 1.06e-17 | 51 |
immune system cancer | 1.06e-17 | 51 |
leukemia | 1.16e-13 | 39 |
myeloid leukemia | 2.02e-09 | 31 |
lymphoma | 2.46e-07 | 10 |
Showing 1 to 10 of 11 entries